{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:32:57Z","timestamp":1792427577461,"version":"4.5.0"},"reference-count":180,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of Health","award":["851\/23"],"award-info":[{"award-number":["851\/23"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The endocannabinoid system (ECS), composed of receptors, endocannabinoids, and enzymes that regulate biosynthesis and degradation, plays a fundamental role in the physiology and pathology of the gastrointestinal tract, particularly in the small and large intestine and liver. Specifically, cannabinoid receptor type 1 (CB1R) and cannabinoid receptor type 2 (CB2R), located principally in the nervous system and immune cells, orchestrate processes such as intestinal motility, intestinal and hepatic inflammation, and energy metabolism, respectively. The main endocannabinoids, anandamide (AEA) and 2-arachidonoylglycerol (2-AG), influence appetite, body weight regulation, and inflammatory states and thus have implications in obesity, non-alcoholic fatty liver disease (NAFLD) and irritable bowel syndrome (IBS). Recent studies have highlighted the therapeutic potential of targeting the ECS to modulate gastrointestinal and metabolic diseases. In particular, peripheral CB1R antagonists and CB2R agonists have shown efficacy in treating intestinal inflammation, reducing hepatic steatosis, and controlling IBS symptoms. Moreover, the ECS is emerging as a potential target for the treatment of colorectal cancer, acting on cell proliferation and apoptosis. This review highlights the opportunity to exploit the endocannabinoid system in the search for innovative therapeutic strategies, emphasizing the importance of a targeted approach to optimize treatment efficacy and minimize side effects.<\/jats:p>","DOI":"10.3390\/ijms26031306","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T12:18:56Z","timestamp":1738585136000},"page":"1306","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The Endocannabinoid System: Implications in Gastrointestinal Physiology and Pathology"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2969-5052","authenticated-orcid":false,"given":"Emanuela","family":"Aloisio Caruso","sequence":"first","affiliation":[{"name":"Laboratory of Nutritional Biochemistry, National Institute of Gastroenterology IRCCS \u201cSaverio de Bellis\u201d, 70013 Castellana Grotte, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7912-9023","authenticated-orcid":false,"given":"Valentina","family":"De Nunzio","sequence":"additional","affiliation":[{"name":"Laboratory of Nutritional Biochemistry, National Institute of Gastroenterology IRCCS \u201cSaverio de Bellis\u201d, 70013 Castellana Grotte, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Tutino","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pathology, National Institute of Gastroenterology IRCCS \u201cSaverio de Bellis\u201d, 70013 Castellana Grotte, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2274-2198","authenticated-orcid":false,"given":"Maria","family":"Notarnicola","sequence":"additional","affiliation":[{"name":"Laboratory of Nutritional Biochemistry, National Institute of Gastroenterology IRCCS \u201cSaverio de Bellis\u201d, 70013 Castellana Grotte, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0026-895X(25)09876-1","article-title":"Determination and Characterization of a Cannabinoid Receptor in Rat Brain","volume":"34","author":"Devane","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1590\/S1516-44462006000200015","article-title":"History of Cannabis as a Medicine: A Review","volume":"28","author":"Zuardi","year":"2006","journal-title":"Rev. Bras. Psiquiatr."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"G655","DOI":"10.1152\/ajpgi.00294.2015","article-title":"Endocannabinoids in the Gastrointestinal Tract","volume":"311","author":"Lee","year":"2016","journal-title":"Am. J. Physiol. -Gastrointest. Liver Physiol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Battista, N., Di Tommaso, M., Bari, M., and Maccarrone, M. (2012). The Endocannabinoid System: An Overview. Front. Behav. Neurosci., 6.","DOI":"10.3389\/fnbeh.2012.00009"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an Endogenous 2-Monoglyceride, Present in Canine Gut, That Binds to Cannabinoid Receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"17078","DOI":"10.3390\/molecules191117078","article-title":"Endocannabinoids, Related Compounds and Their Metabolic Routes","volume":"19","author":"Fezza","year":"2014","journal-title":"Molecules"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Simard, M., Archambault, A.-S., Lavoie, J.-P.C., Dumais, \u00c9., Di Marzo, V., and Flamand, N. (2022). Biosynthesis and Metabolism of Endocannabinoids and Their Congeners from the Monoacylglycerol and N-Acyl-Ethanolamine Families. Biochem. Pharmacol., 205.","DOI":"10.1016\/j.bcp.2022.115261"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/bs.apha.2017.03.007","article-title":"CB 1 and CB 2 Receptor Pharmacology","volume":"80","author":"Howlett","year":"2017","journal-title":"Adv. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a Cannabinoid Receptor and Functional Expression of the Cloned CDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd1495","article-title":"De The Endocannabinoid System and Its Therapeutic Exploitation","volume":"3","author":"Marzo","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid Receptor Localization in Brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0306-4522(97)00436-3","article-title":"Immunohistochemical Distribution of Cannabinoid CB1 Receptors in the Rat Central Nervous System","volume":"83","author":"Tsou","year":"1998","journal-title":"Neuroscience"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","article-title":"Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations","volume":"232","author":"Mary","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI200523057","article-title":"Endocannabinoid Activation at Hepatic CB1 Receptors Stimulates Fatty Acid Synthesis and Contributes to Diet-Induced Obesity","volume":"115","author":"DePetrillo","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00535-009-0122-y","article-title":"Hepatic Expression of Endocannabinoid Receptors and Their Novel Polymorphisms in Primary Biliary Cirrhosis","volume":"45","author":"Floreani","year":"2010","journal-title":"J. Gastroenterol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0167-4781(02)00341-X","article-title":"Cloning and Molecular Characterization of the Rat CB2 Cannabinoid Receptor","volume":"1576","author":"Brown","year":"2002","journal-title":"Biochim. Biophys. Acta BBA\u2014Gene Struct. Expr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/hep.24077","article-title":"Endocannabinoids in Liver Disease","volume":"53","author":"Tam","year":"2011","journal-title":"Hepatology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nri1602","article-title":"Cannabinoid-Based Drugs as Anti-Inflammatory Therapeutics","volume":"5","author":"Klein","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1478-3231.2006.01401.x","article-title":"Endocannabinoid Receptor CB2 in Nonalcoholic Fatty Liver Disease","volume":"27","author":"Uribe","year":"2007","journal-title":"Liver Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1053\/j.gastro.2004.12.050","article-title":"Antifibrogenic Role of the Cannabinoid Receptor CB2 in the Liver","volume":"128","author":"Julien","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cancergencyto.2006.06.014","article-title":"Overexpression of Cannabinoid Receptors CB1 and CB2 Correlates with Improved Prognosis of Patients with Hepatocellular Carcinoma","volume":"171","author":"Xu","year":"2006","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.neuropharm.2012.05.013","article-title":"WIN55212-2 Attenuates Amyloid-Beta-Induced Neuroinflammation in Rats through Activation of Cannabinoid Receptors and PPAR-\u03b3 Pathway","volume":"63","author":"Fakhfouri","year":"2012","journal-title":"Neuropharmacology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ptr.5095","article-title":"Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5Y APP+ Cells Through PPAR\u03b3 Involvement","volume":"28","author":"Scuderi","year":"2014","journal-title":"Phytother. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.2174\/092986710790980014","article-title":"From Surface to Nuclear Receptors: The Endocannabinoid Family Extends Its Assets","volume":"17","author":"Pistis","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejphar.2005.05.032","article-title":"Anandamide Induced PPAR\u03b3 Transcriptional Activation and 3T3-L1 Preadipocyte Differentiation","volume":"517","author":"Bouaboula","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"ref_27","first-page":"357","article-title":"Peroxisome Proliferator-Activated Receptor(PPAR)--Structure, Function, Tissue Distribution, Gene Expression","volume":"58","author":"Takeyama","year":"2000","journal-title":"Nihon Rinsho"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/35013000","article-title":"Roles of PPARs in Health and Disease","volume":"405","author":"Kersten","year":"2000","journal-title":"Nature"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Iannotti, F.A., and Vitale, R.M. (2021). The Endocannabinoid System and PPARs: Focus on Their Signalling Crosstalk, Action and Transcriptional Regulation. Cells, 10.","DOI":"10.3390\/cells10030586"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1124\/mol.105.019117","article-title":"Interleukin-2 Suppression by 2-Arachidonyl Glycerol Is Mediated through Peroxisome Proliferator-Activated Receptor \u03b3 Independently of Cannabinoid Receptors 1 and 2","volume":"70","author":"Rockwell","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Muller, C., Morales, P., and Reggio, P.H. (2019). Cannabinoid Ligands Targeting TRP Channels. Front. Mol. Neurosci., 11.","DOI":"10.3389\/fnmol.2018.00487"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of Cannabinoids and Cannabinoid-enriched Cannabis Extracts on TRP Channels and Endocannabinoid Metabolic Enzymes","volume":"163","author":"Ligresti","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0026-895X(25)15066-9","article-title":"Cannabinoid Inhibition of Adenylate Cyclase. Pharmacology of the Response in Neuroblastoma Cell Membranes","volume":"26","author":"Howlett","year":"1984","journal-title":"Mol. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0163-7258(97)82001-3","article-title":"Pharmacology of Cannabinoid CB1 and CB2 Receptors","volume":"74","author":"Pertwee","year":"1997","journal-title":"Pharmacol. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0009-3084(00)00187-0","article-title":"Cellular Signal Transduction by Anandamide and 2-Arachidonoylglycerol","volume":"108","author":"Howlett","year":"2000","journal-title":"Chem. Phys. Lipids"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1189\/jlb.3HI1214-584R","article-title":"Human Lung-Resident Macrophages Express CB1 and CB2 Receptors Whose Activation Inhibits the Release of Angiogenic and Lymphangiogenic Factors","volume":"99","author":"Staiano","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1471-4159.2007.04642.x","article-title":"Regulation of PI3K\/Akt\/GSK-3 Pathway by Cannabinoids in the Brain","volume":"102","author":"Ozaita","year":"2007","journal-title":"J. Neurochem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.282.5392.1318","article-title":"Regulation of Cell Death Protease Caspase-9 by Phosphorylation","volume":"282","author":"Cardone","year":"1998","journal-title":"Science"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"154338","DOI":"10.1016\/j.metabol.2020.154338","article-title":"The Role of Peroxisome Proliferator-Activated Receptors (PPAR) in Immune Responses","volume":"114","author":"Christofides","year":"2021","journal-title":"Metabolism"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"925309","DOI":"10.1155\/2009\/925309","article-title":"Cross-Talk between PPARs and the Partners of RXR: A Molecular Perspective","volume":"2009","author":"Chan","year":"2009","journal-title":"PPAR Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1021\/cn5000524","article-title":"Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability","volume":"5","author":"Iannotti","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"101087","DOI":"10.1016\/j.molmet.2020.101087","article-title":"Reversal of Diet-Induced Hepatic Steatosis by Peripheral CB1 Receptor Blockade in Mice Is P53\/MiRNA-22\/SIRT1\/PPAR\u03b1 Dependent","volume":"42","author":"Azar","year":"2020","journal-title":"Mol. Metab."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1210\/jc.2007-0768","article-title":"The Endogenous Cannabinoid System Stimulates Glucose Uptake in Human Fat Cells via Phosphatidylinositol 3-Kinase and Calcium-Dependent Mechanisms","volume":"92","author":"Pagano","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1210\/jc.2005-2679","article-title":"Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and \u03b2-Pancreatic Cells and in Obesity and Hyperglycemia","volume":"91","author":"Matias","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.bbrc.2013.05.108","article-title":"Activation of Type 2 Cannabinoid Receptors (CB2R) Promotes Fatty Acid Oxidation through the SIRT1\/PGC-1\u03b1 Pathway","volume":"436","author":"Zheng","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Guida, F., Luongo, L., Boccella, S., Giordano, M.E., Romano, R., Bellini, G., Manzo, I., Furiano, A., Rizzo, A., and Imperatore, R. (2017). Palmitoylethanolamide Induces Microglia Changes Associated with Increased Migration and Phagocytic Activity: Involvement of the CB2 Receptor. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-00342-1"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/bph.12029","article-title":"Activation and Desensitization of TRPV1 Channels in Sensory Neurons by the PPAR\u03b1 Agonist Palmitoylethanolamide","volume":"168","author":"Ambrosino","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1111\/bph.13514","article-title":"Capsaicin Induces Browning of White Adipose Tissue and Counters Obesity by Activating TRPV1 Channel-dependent Mechanisms","volume":"173","author":"Baskaran","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"ref_49","first-page":"47","article-title":"Endocannabinoids and the Gastrointestinal Tract","volume":"29","author":"Massa","year":"2006","journal-title":"J. Endocrinol. Investig."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/153537020523000401","article-title":"Endocannabinoids and Food Intake: Newborn Suckling and Appetite Regulation in Adulthood","volume":"230","author":"Fride","year":"2005","journal-title":"Exp. Biol. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0091-6773(75)91684-3","article-title":"Cannabis: Effects on Hunger and Thirst","volume":"15","author":"Abel","year":"1975","journal-title":"Behav. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/BF02244199","article-title":"Facilitory Effect of \u03949-Tetrahydrocannabinol on Hypothalamically Induced Feeding","volume":"103","author":"Trojniar","year":"1991","journal-title":"Psychopharmacology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002130050953","article-title":"Anandamide Induces Overeating: Mediation by Central Cannabinoid (CB1) Receptors","volume":"143","author":"Williams","year":"1999","journal-title":"Psychopharmacology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/sj.bjp.0704379","article-title":"Anandamide Administration into the Ventromedial Hypothalamus Stimulates Appetite in Rats","volume":"134","author":"Jamshidi","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/sj.bjp.0704767","article-title":"Di Endocannabinoid Levels in Rat Limbic Forebrain and Hypothalamus in Relation to Fasting, Feeding and Satiation: Stimulation of Eating by 2-arachidonoyl Glycerol","volume":"136","author":"Kirkham","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0006-8993(03)03046-4","article-title":"Short-Term Fasting and Prolonged Semistarvation Have Opposite Effects on 2-AG Levels in Mouse Brain","volume":"983","author":"Avraham","year":"2003","journal-title":"Brain Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.phrs.2003.12.006","article-title":"Oleoylethanolamide Inhibits Food Intake in Free-Feeding Rats after Oral Administration","volume":"49","author":"Oveisi","year":"2004","journal-title":"Pharmacol. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2982.2006.00834.x","article-title":"Effect of a Cannabinoid Agonist on Gastrointestinal Transit and Postprandial Satiation in Healthy Human Subjects: A Randomized, Placebo-controlled Study","volume":"18","author":"Esfandyari","year":"2006","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.coph.2004.05.007","article-title":"The Gastrointestinal Pharmacology of Cannabinoids: An Update","volume":"4","author":"Coutts","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1192\/j.eurpsy.2023.2411","article-title":"Association of Anandamide and 2-Arachidonoylglycerol Concentrations with Clinical Features and Body Mass Index in Eating Disorders and Obesity","volume":"66","author":"Baenas","year":"2023","journal-title":"Eur. Psychiatry"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.2337\/diabetes.54.10.2838","article-title":"Activation of the Peripheral Endocannabinoid System in Human Obesity","volume":"54","author":"Engeli","year":"2005","journal-title":"Diabetes"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.2337\/db06-0812","article-title":"Dysregulation of the Peripheral and Adipose Tissue Endocannabinoid System in Human Abdominal Obesity","volume":"55","author":"Engeli","year":"2006","journal-title":"Diabetes"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/sj.ijo.0803539","article-title":"Circulating Endocannabinoid Levels, Abdominal Adiposity and Related Cardiometabolic Risk Factors in Obese Men","volume":"31","author":"Matias","year":"2007","journal-title":"Int. J. Obes."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1523\/JNEUROSCI.2648-09.2010","article-title":"Alterations in the Hippocampal Endocannabinoid System in Diet-Induced Obese Mice","volume":"30","author":"Massa","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","article-title":"Effects of the Cannabinoid-1 Receptor Blocker Rimonabant on Weight Reduction and Cardiovascular Risk Factors in Overweight Patients: 1-Year Experience from the RIO-Europe Study","volume":"365","author":"Rissanen","year":"2005","journal-title":"Lancet"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"S229","DOI":"10.2337\/dc08-s258","article-title":"Efficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight\/Obese Patients","volume":"31","author":"McCarthy","year":"2008","journal-title":"Diabetes Care"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2826.2008.01681.x","article-title":"CB1 Receptor Blockade and Its Impact on Cardiometabolic Risk Factors: Overview of the RIO Programme with Rimonabant","volume":"20","author":"Scheen","year":"2008","journal-title":"J. Neuroendocrinol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1476-5381.2010.00908.x","article-title":"A Novel Peripherally Restricted Cannabinoid Receptor Antagonist, AM6545, Reduces Food Intake and Body Weight, but Does Not Cause Malaise, in Rodents","volume":"161","author":"Cluny","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2012.07.002","article-title":"Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance","volume":"16","author":"Tam","year":"2012","journal-title":"Cell Metab."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/sj.ijo.0802583","article-title":"CB1 Cannabinoid Receptor Knockout in Mice Leads to Leanness, Resistance to Diet-Induced Obesity and Enhanced Leptin Sensitivity","volume":"28","author":"Delgorge","year":"2004","journal-title":"Int. J. Obes."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Srivastava, R.K., Ruiz de Azua, I., Conrad, A., Purrio, M., and Lutz, B. (2022). Cannabinoid CB1 Receptor Deletion from Catecholaminergic Neurons Protects from Diet-Induced Obesity. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232012635"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1172\/JCI83626","article-title":"Adipocyte Cannabinoid Receptor CB1 Regulates Energy Homeostasis and Alternatively Activated Macrophages","volume":"127","author":"Mancini","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Verty, A.N.A., Stefanidis, A., McAinch, A.J., Hryciw, D.H., and Oldfield, B. (2015). Anti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Mice. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0140592"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/syn.20714","article-title":"A Nonsynonymous Polymorphism in Cannabinoid CB2 Receptor Gene Is Associated with Eating Disorders in Humans and Food Intake Is Modified in Mice by Its Ligands","volume":"64","author":"Ishiguro","year":"2010","journal-title":"Synapse"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1007\/s00125-010-1894-6","article-title":"Deficiency of CB2 Cannabinoid Receptor in Mice Improves Insulin Sensitivity but Increases Food Intake and Obesity with Age","volume":"53","author":"Agudo","year":"2010","journal-title":"Diabetologia"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/ijo.2015.169","article-title":"Pro-Inflammatory Obesity in Aged Cannabinoid-2 Receptor-Deficient Mice","volume":"40","author":"Schmitz","year":"2016","journal-title":"Int. J. Obes."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1210\/jc.2015-4381","article-title":"Cannabinoid Receptor 2 as Antiobesity Target: Inflammation, Fat Storage, and Browning Modulation","volume":"101","author":"Rossi","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/sj.ijo.0803510","article-title":"Association between Cannabinoid Type-1 Receptor Polymorphism and Body Mass Index in a Southern Italian Population","volume":"31","author":"Gazzerro","year":"2007","journal-title":"Int. J. Obes."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/dom.15353","article-title":"Effects of CB1R Inverse Agonist, INV-202, in Patients with Features of Metabolic Syndrome. A Randomized, Placebo-controlled, Double-blind Phase 1b Study","volume":"26","author":"Crater","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-2999(94)00618-H","article-title":"Effect of Phenylmethylsulphonyl Fluoride on the Potency of Anandamide as an Inhibitor of Electrically Evoked Contractions in Two Isolated Tissue Preparations","volume":"272","author":"Pertwee","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1139\/y98-021","article-title":"Evidence That Cannabinoid-Induced Inhibition of Electrically Evoked Contractions of the Myenteric Plexus--Longitudinal Muscle Preparation of Guinea-Pig Small Intestine Can Be Modulated by Ca2+ and CAMP","volume":"76","author":"Coutts","year":"1998","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bjp.0704220","article-title":"Differential Effects of Anandamide on Acetylcholine Release in the Guinea-pig Ileum Mediated via Vanilloid and Non-CB 1 Cannabinoid Receptors","volume":"134","author":"Mang","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/gast.2002.34242","article-title":"Endocannabinoids as Physiological Regulators of Colonic Propulsion in Mice","volume":"123","author":"Pinto","year":"2002","journal-title":"Gastroenterology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/j.gastro.2005.06.018","article-title":"Fatty Acid Amide Hydrolase Controls Mouse Intestinal Motility In Vivo","volume":"129","author":"Capasso","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/nmo.12272","article-title":"Selective Inhibition of FAAH Produces Antidiarrheal and Antinociceptive Effect Mediated by Endocannabinoids and Cannabinoid-like Fatty Acid Amides","volume":"26","author":"Fichna","year":"2014","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"G539","DOI":"10.1152\/ajpgi.00064.2009","article-title":"Modulation of Motor and Sensory Pathways of the Peristaltic Reflex by Cannabinoids","volume":"297","author":"Grider","year":"2009","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/sj.bjp.0705889","article-title":"Effects of Cannabinoid Receptor-2 Activation on Accelerated Gastrointestinal Transit in Lipopolysaccharide-treated Rats","volume":"142","author":"Mathison","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/sj.bjp.0706710","article-title":"Cannabinoid 1 (CB1) Receptors Coupled to Cholinergic Motorneurones Inhibit Neurogenic Circular Muscle Contractility in the Human Colon","volume":"148","author":"Hinds","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1016\/j.cgh.2023.07.008","article-title":"A Randomized, Controlled Trial of Efficacy and Safety of Cannabidiol in Idiopathic and Diabetic Gastroparesis","volume":"21","author":"Zheng","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hep.21641","article-title":"Rimonabant Reduces Obesity-Associated Hepatic Steatosis and Features of Metabolic Syndrome in Obese Zucker Fa\/Fa Rats","volume":"46","author":"Elachouri","year":"2007","journal-title":"Hepatology"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1172\/JCI42551","article-title":"Peripheral CB1 Cannabinoid Receptor Blockade Improves Cardiometabolic Risk in Mouse Models of Obesity","volume":"120","author":"Tam","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/j.1478-3231.2010.02298.x","article-title":"Cannabinoid Receptor 1 and 2 Agonists Increase Lipid Accumulation in Hepatocytes","volume":"30","author":"Spahr","year":"2010","journal-title":"Liver Int."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Deveaux, V., Cadoudal, T., Ichigotani, Y., Teixeira-Clerc, F., Louvet, A., Manin, S., Nhieu, J.T.-V., Belot, M.P., Zimmer, A., and Even, P. (2009). Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0005844"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/oby.21687","article-title":"Serum Levels of Endocannabinoids Are Independently Associated with Nonalcoholic Fatty Liver Disease","volume":"25","author":"Azar","year":"2017","journal-title":"Obesity"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1053\/j.gastro.2010.06.064","article-title":"Splanchnic Balance of Free Fatty Acids, Endocannabinoids, and Lipids in Subjects with Nonalcoholic Fatty Liver Disease","volume":"139","author":"Westerbacka","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nm1421","article-title":"CB1 Cannabinoid Receptor Antagonism: A New Strategy for the Treatment of Liver Fibrosis","volume":"12","author":"Julien","year":"2006","journal-title":"Nat. Med."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Zhou, X., Yang, L., Fan, X., Zhao, X., Chang, N., Yang, L., and Li, L. (2020). Neutrophil Chemotaxis and NETosis in Murine Chronic Liver Injury via Cannabinoid Receptor 1\/G\u03b1i\/o\/ROS\/P38 MAPK Signaling Pathway. Cells, 9.","DOI":"10.3390\/cells9020373"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jama.2015.0954","article-title":"Irritable Bowel Syndrome","volume":"313","author":"Chey","year":"2015","journal-title":"JAMA"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel Disorders","volume":"150","author":"Lacy","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/cne.10270","article-title":"Localisation of Cannabinoid CB1 Receptor Immunoreactivity in the Guinea Pig and Rat Myenteric Plexus","volume":"448","author":"Coutts","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"G78","DOI":"10.1152\/ajpgi.90285.2008","article-title":"Cannabinoid CB2 Receptors in the Enteric Nervous System Modulate Gastrointestinal Contractility in Lipopolysaccharide-Treated Rats","volume":"295","author":"Duncan","year":"2008","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/BF01296097","article-title":"Intestinal Motility in Irritable Bowel Syndrome: Is IBS a Motility Disorder?","volume":"38","author":"McKee","year":"1993","journal-title":"Dig. Dis. Sci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/j.1572-0241.2001.03804.x","article-title":"Colonic Motility Abnormality in Patients with Irritable Bowel Syndrome Exhibiting Abdominal Pain and Diarrhea","volume":"96","author":"Chey","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/gut.24.5.405","article-title":"Irritable Bowel Syndrome: Relationship of Disorders in the Transit of a Single Solid Meal to Symptom Patterns","volume":"24","author":"Cann","year":"1983","journal-title":"Gut"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000075554","article-title":"Abnormal Colonic Propagated Activity in Patients with Slow Transit Constipation and Constipation-Predominant Irritable Bowel Syndrome","volume":"68","author":"Bassotti","year":"2003","journal-title":"Digestion"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/BF01395503","article-title":"Irritable Bowel Syndrome","volume":"25","author":"Whitehead","year":"1980","journal-title":"Dig. Dis. Sci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI200419465","article-title":"The Endogenous Cannabinoid System Protects against Colonic Inflammation","volume":"113","author":"Massa","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1096\/fj.05-4943fje","article-title":"Up-regulation of Anandamide Levels as an Endogenous Mechanism and a Pharmacological Strategy to Limit Colon Inflammation","volume":"20","author":"Valenti","year":"2006","journal-title":"FASEB J."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"808","DOI":"10.2337\/db14-0721","article-title":"Acute Activation of Cannabinoid Receptors by Anandamide Reduces Gastrointestinal Motility and Improves Postprandial Glycemia in Mice","volume":"64","author":"Demizieux","year":"2015","journal-title":"Diabetes"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"G137","DOI":"10.1152\/ajpgi.00565.2006","article-title":"Effects of a Cannabinoid Receptor Agonist on Colonic Motor and Sensory Functions in Humans: A Randomized, Placebo-Controlled Study","volume":"293","author":"Esfandyari","year":"2007","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2982.2011.01874.x","article-title":"Randomized Pharmacodynamic and Pharmacogenetic Trial of Dronabinol Effects on Colon Transit in Irritable Bowel Syndrome-diarrhea","volume":"24","author":"Wong","year":"2012","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1053\/j.gastro.2011.07.036","article-title":"Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients with Nonconstipated Irritable Bowel Syndrome","volume":"141","author":"Wong","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/PL00005325","article-title":"Defaecation, Intestinal Fluid Accumulation and Motility in Rodents: Implications of Cannabinoid CB1 Receptors","volume":"359","author":"Izzo","year":"1999","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e550","DOI":"10.1111\/nmo.12158","article-title":"The Cannabinoid-1 Receptor Inverse Agonist Taranabant Reduces Abdominal Pain and Increases Intestinal Transit in Mice","volume":"25","author":"Fichna","year":"2013","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"G13","DOI":"10.1152\/ajpgi.00371.2007","article-title":"Genetic Variation in Endocannabinoid Metabolism, Gastrointestinal Motility, and Sensation","volume":"294","author":"Camilleri","year":"2008","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Fichna, J., Wood, J.T., Papanastasiou, M., Vadivel, S.K., Oprocha, P., Sa\u0142aga, M., Sobczak, M., Mokrowiecka, A., Cygankiewicz, A.I., and Zakrzewski, P.K. (2013). Endocannabinoid and Cannabinoid-like Fatty Acid Amide Levels Correlate with Pain-Related Symptoms in Patients with IBS-D and IBS-C: A Pilot Study. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0085073"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/sj.bjp.0704339","article-title":"Inhibitory Effect of Palmitoylethanolamide on Gastrointestinal Motility in Mice","volume":"134","author":"Capasso","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1365-2982.2008.01248.x","article-title":"The Identification of Peroxisome Proliferator-activated Receptor Alpha-independent Effects of Oleoylethanolamide on Intestinal Transit in Mice","volume":"21","author":"Cluny","year":"2009","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/gut.2007.138982","article-title":"Increased Capsaicin Receptor TRPV1-Expressing Sensory Fibres in Irritable Bowel Syndrome and Their Correlation with Abdominal Pain","volume":"57","author":"Akbar","year":"2008","journal-title":"Gut"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/j.gastro.2015.12.034","article-title":"Histamine Receptor H1\u2013Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome","volume":"150","author":"Wouters","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1096\/fj.201500132","article-title":"Oleoylethanolamine and Palmitoylethanolamine Modulate Intestinal Permeability in Vitro via TRPV1 and PPAR\u03b1","volume":"31","author":"Karwad","year":"2017","journal-title":"FASEB J."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.neuroscience.2007.05.034","article-title":"The Role of Transient Receptor Potential Vanilloid 1 in Mechanical and Chemical Visceral Hyperalgesia Following Experimental Colitis","volume":"148","author":"Miranda","year":"2007","journal-title":"Neuroscience"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Gigante, I., Tutino, V., Russo, F., De Nunzio, V., Coletta, S., Armentano, R., Crovace, A., Caruso, M.G., Orlando, A., and Notarnicola, M. (2021). Cannabinoid Receptors Overexpression in a Rat Model of Irritable Bowel Syndrome (IBS) after Treatment with a Ketogenic Diet. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22062880"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/apt.14014","article-title":"Editorial: Diet, Inflammation and Irritable Bowel Syndrome","volume":"45","author":"Quigley","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.pop.2023.03.009","article-title":"Inflammatory Bowel Disease","volume":"50","author":"Bruner","year":"2023","journal-title":"Prim. Care Clin. Off. Pract."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cgh.2013.04.034","article-title":"Cannabis Induces a Clinical Response in Patients With Crohn\u2019s Disease: A Prospective Placebo-Controlled Study","volume":"11","author":"Naftali","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/mi.2011.18","article-title":"The Endogenous Cannabinoid System in the Gut of Patients with Inflammatory Bowel Disease","volume":"4","author":"Battista","year":"2011","journal-title":"Mucosal Immunol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1097\/MEG.0000000000001565","article-title":"Medical Cannabis for Inflammatory Bowel Disease: Real-Life Experience of Mode of Consumption and Assessment of Side-Effects","volume":"31","author":"Naftali","year":"2019","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Tartakover Matalon, S., Azar, S., Meiri, D., Hadar, R., Nemirovski, A., Abu Jabal, N., Konikoff, F.M., Drucker, L., Tam, J., and Naftali, T. (2021). Endocannabinoid Levels in Ulcerative Colitis Patients Correlate with Clinical Parameters and Are Affected by Cannabis Consumption. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.685289"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.drugalcdep.2015.08.035","article-title":"Patterns of Cannabis Use in Patients with Inflammatory Bowel Disease: A Population Based Analysis","volume":"156","author":"Weiss","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/MEG.0b013e328349bb4c","article-title":"Cannabis Use amongst Patients with Inflammatory Bowel Disease","volume":"23","author":"Lal","year":"2011","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/08923973.2024.2445733","article-title":"Cannabis Sativa Alleviates Experimentally Acetic Acid- Induced Ulcerative Colitis in Rats: Targeting CB1\/SIRT\/MAPK Signaling Pathways","volume":"47","author":"Elgohary","year":"2025","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal Cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"329","DOI":"10.6004\/jnccn.2021.0012","article-title":"Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Benson","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ajco.13119","article-title":"First-line Therapy for Metastatic Colorectal Cancer: Current Perspectives and Future Directions","volume":"15","author":"Burge","year":"2019","journal-title":"Asia-Pac. J. Clin. Oncol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s41419-018-0810-8","article-title":"Suppression of Notch1 and AKT Mediated Epithelial to Mesenchymal Transition by Verrucarin J in Metastatic Colon Cancer","volume":"9","author":"Pal","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/jnci\/55.3.597","article-title":"Antineoplastic Activity of Cannabinoids","volume":"55","author":"Munson","year":"1975","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1073\/pnas.95.14.8375","article-title":"The Endogenous Cannabinoid Anandamide Inhibits Human Breast Cancer Cell Proliferation","volume":"95","author":"Melck","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/73171","article-title":"Anti-Tumoral Action of Cannabinoids: Involvement of Sustained Ceramide Accumulation and Extracellular Signal-Regulated Kinase Activation","volume":"6","author":"Izquierdo","year":"2000","journal-title":"Nat. Med."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.bjc.6603236","article-title":"A Pilot Clinical Study of \u03949-Tetrahydrocannabinol in Patients with Recurrent Glioblastoma Multiforme","volume":"95","author":"Duarte","year":"2006","journal-title":"Br. J. Cancer"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s001090000177","article-title":"Control of the Cell Survival\/Death Decision by Cannabinoids","volume":"78","year":"2001","journal-title":"J. Mol. Med."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nrc1188","article-title":"Cannabinoids: Potential Anticancer Agents","volume":"3","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1158\/0008-5472.CAN-03-3927","article-title":"Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas","volume":"64","author":"Alvarez","year":"2004","journal-title":"Cancer Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/bj3630183","article-title":"De Novo-Synthesized Ceramide Is Involved in Cannabinoid-Induced Apoptosis","volume":"363","author":"Pulgar","year":"2002","journal-title":"Biochem. J."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1080\/15548627.2016.1213927","article-title":"Dihydroceramide Accumulation Mediates Cytotoxic Autophagy of Cancer Cells via Autolysosome Destabilization","volume":"12","author":"Salanueva","year":"2016","journal-title":"Autophagy"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/cdd.2011.32","article-title":"Anti-Tumoral Action of Cannabinoids on Hepatocellular Carcinoma: Role of AMPK-Dependent Activation of Autophagy","volume":"18","author":"Vara","year":"2011","journal-title":"Cell Death Differ."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1096\/fj.06-6638fje","article-title":"Cannabinoid Receptors as Novel Targets for the Treatment of Melanoma","volume":"20","author":"Carracedo","year":"2006","journal-title":"FASEB J."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1002\/ijc.22917","article-title":"The Cannabinoid \u03949-tetrahydrocannabinol Inhibits RAS-MAPK and PI3K-AKT Survival Signalling and Induces BAD-mediated Apoptosis in Colorectal Cancer Cells","volume":"121","author":"Greenhough","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0016-5085(03)00881-3","article-title":"Possible Endocannabinoid Control of Colorectal Cancer Growth","volume":"125","author":"Ligresti","year":"2003","journal-title":"Gastroenterology"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"7691","DOI":"10.1158\/1078-0432.CCR-08-0799","article-title":"Cannabinoid Receptor Activation Induces Apoptosis through Tumor Necrosis Factor \u03b1\u2013Mediated Ceramide De Novo Synthesis in Colon Cancer Cells","volume":"14","author":"Cianchi","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1158\/0008-5472.CAN-08-0896","article-title":"Loss of Cannabinoid Receptor 1 Accelerates Intestinal Tumor Growth","volume":"68","author":"Wang","year":"2008","journal-title":"Cancer Res."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1136\/gut.2005.073403","article-title":"The Endogenous Cannabinoid, Anandamide, Induces Cell Death in Colorectal Carcinoma Cells: A Possible Role for Cyclooxygenase 2","volume":"54","author":"Patsos","year":"2005","journal-title":"Gut"},{"key":"ref_154","first-page":"187","article-title":"The Endogenous Cannabinoid, Anandamide, Induces COX-2-Dependent Cell Death in Apoptosis-Resistant Colon Cancer Cells","volume":"37","author":"Patsos","year":"2010","journal-title":"Int. J. Oncol."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Benedicto, A., Arteta, B., Duranti, A., and Alonso-Alconada, D. (2022). The Synthetic Cannabinoid URB447 Exerts Antitumor and Antimetastatic Effect in Melanoma and Colon Cancer. Pharmaceuticals, 15.","DOI":"10.3390\/ph15101166"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"108865","DOI":"10.1016\/j.intimp.2022.108865","article-title":"Cannabidiol Exerts Anti-Proliferative Activity via a Cannabinoid Receptor 2-Dependent Mechanism in Human Colorectal Cancer Cells","volume":"108","author":"Lee","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1007\/s11010-021-04158-6","article-title":"Cannabinoids Pharmacological Effects Are beyond the Palliative Effects: CB2 Cannabinoid Receptor Agonist Induced Cytotoxicity and Apoptosis in Human Colorectal Cancer Cells (HT-29)","volume":"476","author":"Alenabi","year":"2021","journal-title":"Mol. Cell. Biochem."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00109-011-0856-x","article-title":"Chemopreventive Effect of the Non-Psychotropic Phytocannabinoid Cannabidiol on Experimental Colon Cancer","volume":"90","author":"Aviello","year":"2012","journal-title":"J. Mol. Med."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00109-007-0248-4","article-title":"Increased Endocannabinoid Levels Reduce the Development of Precancerous Lesions in the Mouse Colon","volume":"86","author":"Izzo","year":"2008","journal-title":"J. Mol. Med."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/carcin\/bgu205","article-title":"Colon Carcinogenesis Is Inhibited by the TRPM8 Antagonist Cannabigerol, a Cannabis-Derived Non-Psychotropic Cannabinoid","volume":"35","author":"Borrelli","year":"2014","journal-title":"Carcinogenesis"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s40263-018-0578-5","article-title":"A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects","volume":"32","author":"Taylor","year":"2018","journal-title":"CNS Drugs"},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Iden, J.A., Raphael-Mizrahi, B., Awida, Z., Naim, A., Zyc, D., Liron, T., Kasher, M., Livshits, G., Vered, M., and Gabet, Y. (2023). The Anti-Tumorigenic Role of Cannabinoid Receptor 2 in Colon Cancer: A Study in Mice and Humans. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24044060"},{"key":"ref_163","first-page":"2583","article-title":"Effects of Anandamide on Polyamine Levels and Cell Growth in Human Colon Cancer Cells","volume":"30","author":"Linsalata","year":"2010","journal-title":"Anticancer Res."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Tutino, V., Caruso, M.G., De Nunzio, V., Lorusso, D., Veronese, N., Gigante, I., Notarnicola, M., and Giannelli, G. (2019). Down-Regulation of Cannabinoid Type 1 (CB1) Receptor and Its Downstream Signaling Pathways in Metastatic Colorectal Cancer. Cancers, 11.","DOI":"10.3390\/cancers11050708"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/00365520701559011","article-title":"Estrogenic Induction of Cannabinoid CB1 Receptor in Human Colon Cancer Cell Lines","volume":"43","author":"Notarnicola","year":"2008","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1002\/jcp.25026","article-title":"Anti Proliferative and Pro Apoptotic Effects of Flavonoid Quercetin Are Mediated by CB1 Receptor in Human Colon Cancer Cell Lines","volume":"230","author":"Refolo","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.21873\/anticanres.12752","article-title":"Cannabinoid Receptor-1 Up-Regulation in Azoxymethane (AOM)-Treated Mice After Dietary Treatment with Quercetin","volume":"38","author":"Tutino","year":"2018","journal-title":"Anticancer Res."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejim.2018.01.023","article-title":"Prospective Analysis of Safety and Efficacy of Medical Cannabis in Large Unselected Population of Patients with Cancer","volume":"49","author":"Mechoulam","year":"2018","journal-title":"Eur. J. Intern. Med."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jpain.2012.01.003","article-title":"Nabiximols for Opioid-Treated Cancer Patients with Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial","volume":"13","author":"Portenoy","year":"2012","journal-title":"J. Pain"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jpainsymman.2012.07.014","article-title":"An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC\/CBD Oromucosal Spray and Oromucosal THC Spray in Patients with Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics","volume":"46","author":"Johnson","year":"2013","journal-title":"J. Pain Symptom Manag."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3747\/co.23.3080","article-title":"Anticancer Mechanisms of Cannabinoids","volume":"23","author":"Velasco","year":"2016","journal-title":"Curr. Oncol."},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Pagano, C., Navarra, G., Coppola, L., Bifulco, M., and Laezza, C. (2021). Molecular Mechanism of Cannabinoids in Cancer Progression. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073680"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1248\/bpb.35.924","article-title":"Anti-Tumor Activity of the Novel Hexahydrocannabinol Analog LYR-8 in Human Colorectal Tumor Xenograft Is Mediated through the Inhibition of Akt and Hypoxia-Inducible Factor-1\u03b1 Activation","volume":"35","author":"Thapa","year":"2012","journal-title":"Biol. Pharm. Bull."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nm1521","article-title":"Lactobacillus Acidophilus Modulates Intestinal Pain and Induces Opioid and Cannabinoid Receptors","volume":"13","author":"Rousseaux","year":"2007","journal-title":"Nat. Med."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbi.2017.09.001","article-title":"Antibiotic-Induced Microbiota Perturbation Causes Gut Endocannabinoidome Changes, Hippocampal Neuroglial Reorganization and Depression in Mice","volume":"67","author":"Guida","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Castonguay-Paradis, S., Lacroix, S., Rochefort, G., Parent, L., Perron, J., Martin, C., Lamarche, B., Raymond, F., Flamand, N., and Di Marzo, V. (2020). Dietary Fatty Acid Intake and Gut Microbiota Determine Circulating Endocannabinoidome Signaling beyond the Effect of Body Fat. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-72861-3"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Muccioli, G.G., Naslain, D., B\u00e4ckhed, F., Reigstad, C.S., Lambert, D.M., Delzenne, N.M., and Cani, P.D. (2010). The Endocannabinoid System Links Gut Microbiota to Adipogenesis. Mol. Syst. Biol., 6.","DOI":"10.1038\/msb.2010.46"},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Dione, N., Lacroix, S., Taschler, U., Desch\u00eanes, T., Abolghasemi, A., Leblanc, N., Di Marzo, V., and Silvestri, C. (2020). Mgll Knockout Mouse Resistance to Diet-Induced Dysmetabolism Is Associated with Altered Gut Microbiota. Cells, 9.","DOI":"10.3390\/cells9122705"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.cell.2020.09.022","article-title":"Endocannabinoids Inhibit the Induction of Virulence in Enteric Pathogens","volume":"183","author":"Ellermann","year":"2020","journal-title":"Cell"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1194\/jlr.RA119000424","article-title":"Germ-Free Mice Exhibit Profound Gut Microbiota-Dependent Alterations of Intestinal Endocannabinoidome Signaling","volume":"61","author":"Manca","year":"2020","journal-title":"J. Lipid Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/3\/1306\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:26:23Z","timestamp":1760027183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/3\/1306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":180,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["ijms26031306"],"URL":"https:\/\/doi.org\/10.3390\/ijms26031306","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]}}}